Globalization of Biosimilars

This track discuses about the generic drugs impact on global biosimilar market , Cost and risk management, Adopting innovative mechanisms such as risk-sharing arrangement, European market for biosimilars. The global market scenario with the launch of first biosimilar in the market forecasts some radical changes. This track will look upon such key concerns which are witnessed by the global pharma market and that are coming up with the subsequent launch of the other biosimilars and biologics.Despite these emerging facilities, biotherapeutic developers are most comfortable off-shoring to established markets—the US and Europe. In terms of the outsourcing destinations that are most-cited as at least a possibility for outsourcing during the next five years, the leading markets are: USA (78% are at least considering) Germany (76%) Singapore (74%) United Kingdom (73%).

Quick Links

Are you interested in

Copyright © 2017-2018 Allied Academies, All Rights Reserved.